PANASONIC
Panasonic Corporation and the Digital Hollywood University Media Science Laboratory will jointly collaborate with YOHJI YAMAMOTO Co., Ltd. to release the 2017-2018 Autumn/Winter Paris Collection of the renowned Japanese fashion brand YOHJI YAMAMOTO at 8:00 PM March 3, Friday, local Paris time at the Paris Collection, which holds worldwide attention in the fashion industry. The fashion show will be recorded using multiple units of the new Digital Single Lens Mirrorless Cameras, "LUMIX DC-GH5 ", and live streamed on the Internet.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170226005131/en/
Since February 2014, Panasonic has been exploring new image expression methods using 4K technology and developing digital imaging devices that can bring those expressions to life in collaboration with the Tomoyuki Sugiyama Research Department of the Digital Hollywood University Media Science Laboratory.
For this demonstration, Panasonic will provide 5 GH5s, the world's first (*1) Digital Single Lens Mirrorless Camera that can shoot 4K 60p video, to support the Digital Hollywood University's shoot of YOHJI YAMAMOTO's runway at one of the most prominent fashion events, the Paris Collection. Taking advantage of GH5's compact, lightweight features, the runway will be shot from multiple angles in super high resolution 4K 60p with smooth movement. These cameras will demonstrate the excellent power of expression of 4K 60p, which will capture the unique atmosphere and even the texture of the materials at the forefront of fashion. Panasonic is also conducting a live streaming demonstration via the Internet by recording 4K 60p video with GH5, and simultaneously converting it to Full HD with an external device in order to provide a smooth and stable streaming of live images to people in the fashion industry and fashion lovers across the world.
The live streaming will begin from 8:00 PM March 3, Friday, local Paris time (*2) at:
YOHJI YAMAMOTO Official Site
http://www.yohjiyamamoto.co.jp/yy/
YOHJI YAMAMOTO Official Facebook page
https://www.facebook.com/theofficialyohji/
YYChannel - YouTube
https://www.youtube.com/c/YYchannelYohjiYamamoto
Panasonic will continue to develop products that explore new possibilities of image expression technologies unique to elaborate and immersive 4K images that are befitting of the high definition era through the collaboration with Digital Hollywood University, and to create new values for its customers and a new photo and video culture.
*1 As of January 4, 2017. As a digital single lens mirrorless camera, according to Panasonic research.
*2 Please note that the start of Internet streaming may be delayed due to conditions at the fashion show.
Related Links
LUMIX GLOBAL GATEWAY – Panasonic
http://www.panasonic.com/global/consumer/lumix/index.html
[Press Release] Panasonic Develops the World's First 4K 60p/50p Video
Recording Digital Single Lens Mirrorless Camera LUMIX GH5 Featuring '6K
PHOTO' (Sep 20, 2016)
http://news.panasonic.com/global/press/data/2016/09/en160920-5/en160920-5.html
YOHJI YAMAMOTO Official Site
http://www.yohjiyamamoto.co.jp/yy/
Digital Hollywood University | Top
http://www.dhw.ac.jp/en/
Digital Hollywood University Media Science Laboratory (Japanese)
http://msl.dhw.ac.jp/
[Video] Introducing Panasonic LUMIX GH5
https://www.youtube.com/watch?v=2w7T2g8cZWs
[Video] Benefits of LUMIX GH5 at #PanasonicCES 2017
https://www.youtube.com/watch?v=aJeL4WFRSeI
View source version on businesswire.com: http://www.businesswire.com/news/home/20170226005131/en/
Contact:
Media Contacts:
Panasonic Corporation
Global Communications
Department
Media Promotion Office
presscontact@ml.jp.panasonic.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom